Recent developments in the discovery of selective glucocorticoid receptor modulators (SGRMs)

[摘要]：

Steroidal glucocorticoids are widely prescribed for the treatment of a variety of inflammatory and autoimmune diseases. Although they are effective, the side-effects associated with chronic glucocorticoid treatment, such as osteoporosis and hyperglycemia, can severely limit their long-term use. Hence, there is a need to develop new effective anti-inflammatory agents for systemic use which are dissociated from their unwanted side effects.

[全文传递流程]：

一般上传文献全文的时限在1个工作日内